Structural characterization of protein-protein complexes is required to fully understand biological processes. However, such studies can be difficult, particularly when the interactions are transient. In some cases, the covalent linking of weakly interacting binding partners has been shown to facilitate structural studies. Here, we used this approach to investigate, by X-ray crystallography, the interactions between TIR (Toll/interleukin-1 receptor/resistance protein) domains from proteins involved in plant and animal innate immunity. Combinations of TIR domains known to interact were covalently attached using short glycine-and serine-rich linkers. This approach enabled the production of a number of TIR-TIR domain complexes in soluble form, facilitating crystallization studies.
Introduction
Protein-protein interactions are central to essentially all biological processes. Defining the interfaces that contribute to these interactions is pivotal for an understanding of the corresponding biological processes at a molecular level and provides a foundation for applications in medicine, agriculture and biotechnology.
X-ray crystallography serves as a key technique to characterize protein-protein interactions. It relies on obtaining high-quality protein crystals, which require the formation of an ordered array of molecules. However, the weak and transient nature of many biologically relevant protein-protein interactions makes it difficult to capture many complexes in crystals. One faces the challenges of achieving adequate local concentrations of the binding partners and maintaining stoichiometry in environments that promote protein crystallization.
One effective approach to overcome the problems posed by transient interactions for structural studies is the covalent attachment of interacting proteins using short amino acid sequences usually termed linkers. Employing such a linker strategy has enabled structural interpretation of several protein-protein complexes using X-ray crystallography, NMR and cryo-electron microscopy (reviewed by Reddy Chichili et al. (2013) ). For example, the linker strategy was implemented successfully in a crystallographic study of the ternary complex involving D10 T-cell receptor, I-A k self-major histocompatibility class II molecule and a peptide antigen (Reinherz et al., 1999) . In some cases, linkers have been required for the production of interacting proteins in Protein Engineering, Design & Selection, 2015 , vol. 28 no. 5, pp. 137-145 doi: 10.1093 Advance Access Publication Date: 15 March 2015
Original Article soluble form. While investigating the nuclear LIM (Lin-11/Islet-1/ Mec-3)-only zinc-binding transcription factors LMO2 and LMO4, Deane et al. used a short Gly/Ser-rich linker to attach the C-terminal LID segment (38 residues) from the LIM-domain binding protein-1, ldb1 (Deane et al., 2001) . This approach enabled the production of a soluble protein complex in Escherichia coli, which facilitated the solution structure of the complexes of LMO2 and LMO4 with ldb1 (Deane et al., 2003) . Recently, the linker strategy was used in the structural characterization of the assembly formed by the type-II secretion system ATPase GspE EpsE from Vibrio cholerae. By fusing GspE EpsE with the Pseudomonas aeruginosa hexamer-forming secretion system protein Hcp1 (Mougous et al., 2006) , Lu et al. were able to determine the structure of the active hexametric structure (Lu et al., 2013) . The linker strategy has therefore been shown to assist the production of interacting partners in soluble form, the stabilization of multimeric complexes and structural studies of transiently interacting partners including intrinsically unstructured proteins (Lu et al., 2013; Reddy Chichili et al., 2013) . The TIR (Toll/interleukin-1 receptor/resistance protein) domain is a ubiquitous protein-protein interaction domain, utilized in the innate immune system in both mammals and plants (Kawai and Akira, 2010; Bonardi et al., 2012; Ve et al., 2015) . Homotypic interactions between TIR domains are a key component of the activation signaling pathways leading to immunity. In animals, TIR domains are present in the cytosolic segments of Toll-like receptors (TLRs) and in the adaptor molecules MyD88 (myeloid differentiation primary response gene 88), MAL (MyD88 adapter-like or TIRAP), TRIF (TIR domain-containing adapter inducing IFN-β) and TRAM (TRIF-related adapter molecule). Recognition of pathogen-associated molecular patterns by TLRs leads to stabilization of a dimeric form of the receptor that provides a scaffold for recruitment of a single or specific combination of the adaptor proteins through TIR domain interactions (Ve et al., 2012) . In plants, TIR domains are associated with a major sub-class of intracellular nucleotide-binding leucine-rich repeat (NB-LRR) family of resistance receptors (R proteins or NLRs), which resemble mammalian nucleotide-binding oligomerization domain (NOD)-like receptors (Dangl et al., 2013) . These proteins trigger defense responses after perception of pathogen effectors (Jones and Dangl, 2006) . Recent reports have demonstrated that during this response, homotypic interactions of the TIR domains are necessary and sufficient for defense signaling (Swiderski et al., 2009; Krasileva et al., 2010; Bernoux et al., 2011; Williams et al., 2014) .
Most reported dissociation constants for TIR-TIR domain interactions are in the μM range (10-20 μM) (Ve et al., 2015) . Therefore, the transient nature of the TIR domain interactions makes it difficult to define the interaction interfaces that govern these TIR-TIR domain interactions using X-ray crystallography. Consequently, little is known about the molecular basis of homotypic TIR-TIR domain interactions.
Here, we explored the linker strategy to facilitate the co-expression and purification of TIR-TIR domain complexes. By linking TIR domains, we aimed to increase the local concentration of the proteins and promote low-affinity interactions. In addition, as the molecules are physically linked, the stoichiometry between molecules remains constant. We show that the addition of linkers between TIR domains facilitates the expression and purification of most of the TIR-TIR domain complexes investigated. We found that this strategy improved the yield of soluble protein and in two cases enabled the production of soluble TIR domains that could not be produced in a soluble form by themselves. We demonstrate that in two cases the addition of a linker facilitated crystallization of a TIR-TIR domain complex. This 'linker strategy' can therefore be applied to investigate TIR-TIR domain interactions and may have implications for the studies of other proteins with similar structural topologies.
Materials and methods

Plasmid construction
TIR domain fusions were generated using overlap PCR. In brief, two separate PCRs (round 1) were performed to generate the desired 3′ and 5′ linker extensions. The resulting PCR fragments were then mixed and used as a template for the subsequent overlapping PCR (round 2). The combinations of primers used for rounds 1 and 2 PCRs are described in Supplementary Table SI. The final PCR-generated fragment was purified by gel extraction (Qiagen Gel Extraction Kit) and cloned into the pMCSG7 vector using ligation-independent cloning (Stols et al., 2002) , or pET28b (Novagen), using restriction enzyme sites Nco1 and Xho1.
Protein expression and purification
TIR domain fusions were expressed in either E.coli BL21 (DE3) or Rosetta (DE3) cells (detailed in Table I ) using the autoinduction method (Studier, 2005) . In brief, cells were grown with continuous shaking at 37°C until an OD 600nm of 0.8-1 was reached. The temperature was then reduced to 20°C and the cells were grown for a further 18 h before harvesting using centrifugation. For purification, cells were resuspended in the lysis buffer containing 50 mM HEPES ( pH 8.0), 150-500 mM NaCl and 1 mM DTT. The cells were lysed using sonication and clarified by centrifugation (10 000×g) for 40 min. As a first step of purification, the supernatant was applied to a 5-ml HisTrap FF column (GE Healthcare). The column was washed with 20 column volumes of the lysis buffer supplemented with 30 mM imidazole to remove non-specifically bound proteins. The bound protein was eluted with a 30-250 mM linear gradient of imidazole. After analysis by Coomassie-stained SDS-PAGE, fractions that contained the protein of interest were pooled and buffer exchanged into a TEV proteasecompatible cleavage buffer (100 mM Tris, pH 8.0, 250 mM NaCl, 1 mM DTT, 0.05 mM EDTA). Overnight treatment with Ni-affinity purified His-tagged TEV protease (Parks et al., 1994) (∼20 μg/mg of recombinant protein at 4°C) was used to remove the N-terminal 6×His tag. The cleaved protein was reapplied to the HisTrap FF column to remove the TEV protease and other contaminants. Unbound material that contained the protein of interest was concentrated and loaded onto a Superdex 75 HiLoad 26/60 size-exclusion chromatography (SEC) column (GE Healthcare) pre-equilibrated with buffer containing 10 mM HEPES ( pH 7.5), 150 mM NaCl and 1 mM DTT. Fractions containing fusions of interest from mono-disperse peaks were pooled and concentrated to 2-9 mg/ml for crystallization studies.
Protein crystallization
The Pre-Crystallization Test (Hampton Research) was used to screen for the optimal protein concentration for crystallization experiments. Initial screening was prepared using a Mosquito robot (TTP LabTech, UK) in a 96-well format. The hanging drop vapor-diffusion method of crystallization was used, and drops consisting of 100 nl protein solution and 100 nl reservoir solution were equilibrated against 100 μl reservoir solution. Eight commercial screens were utilized: Index, PEG/ Ion and PEGRx (Hampton Research), Morpheus, ProPlex, JCSG Plus, PACT Premier and MIDAS (Molecular Dimensions) and Precipitant Synergy (Jena Biosciences), and an in-house malonate screen (grid screen conditions; 0.2, 0.6, 1.0, 1.5, 1.9, 2.4, 2.9 and 3.4 M malonate at pH 4-7). Hits from the initial crystallization screens were optimized by varying the protein concentration, the precipitant concentration, the pH, the size of the drop and by using additives.
Results
Design of TIR domain fusion proteins
TIR domains have a flavodoxin-like fold (as classified by SCOP (Murzin et al., 1995) ), consisting of five interchanging α-helices and parallel β-strands. Published examples of TIR domains from both plant (L6 TIR , PDB ID 3ozi (Bernoux et al., 2011) ) and animal innate immune systems (TLR2 TIR , PDB ID 1fyv (Xu et al., 2000) ; MAL TIR , PDB ID 2y92 (Valkov et al., 2011) ) demonstrate that the TIR domain will fit within the confines of a box with a width, length and height of 30-35, 40-45 and 30-40 Å, respectively (Fig. 1A) . Since each of the three dimensions are very similar, and the N and C termini are in close proximity on one side of the molecule, a linker that can span the width of a TIR domain will accommodate all possible orientations of the two halves of the complex unless the termini of the two halves are on opposite sides of the interaction interface (Fig. 1B) . The latter complex would require a linker that could span the width of two TIR domains, but based on our analyses of reported TIR-TIR domain interfaces this orientation of the two halves seems unlikely. Several of the reported TIR domain structures (Ve et al., 2015) have additional residues at the N-and/or C-terminus and a shorter linker may therefore also be able to accommodate complex formation without steric restrictions. In light of these characteristics, we utilized two linkers (comprising 5 and 11 residues and termed L5 and L11, respectively) to assist our expression and crystallization studies (Fig. 1C) . L11 can span a maximum of ∼40 Å, which is approximately the length of one TIR domain, whereas L5 can span a maximum of ∼15 Å and would facilitate much more restricted relative orientations between the fused TIR domains. The linkers consisted of Gly and Ser residues, which should provide flexibility and solubility; the DNA encoding the L11 linker further contained an NdeI restriction site to facilitate incorporation of further DNA fragments if required (Deane et al., 2001 ).
Expression and purification of plant TIR domain fusion proteins
The Arabidopsis NLR proteins RRS1 and RPS4 have been shown to function together to confer resistance to three distinct pathogens Narusaka et al., 2009) . We recently demonstrated that these proteins interact directly and identified that heterodimerization of the TIR domains of RPS4 and RRS1 is necessary for function (Williams et al., 2014) . While crystallization of the individual TIR domains was relatively straight-forward (Wan et al., 2013) , the crystallization of the RRS1 TIR -RPS4 TIR complex proved more challenging.
The RPS4 and RRS1 TIR domains formed a heterodimer (1:1 stoichiometry) with a dissociation constant (K d ) of ∼0.5 μM (Williams et al., 2014) . By SEC, the complex eluted in a peak ( peak 1, 155 ml) distinct from RPS4 TIR ( peak 2) or RRS1 TIR alone (Fig. 2B) . However, co-crystallization experiments repeatedly resulted in crystals of RRS1 TIR only. We considered that the precipitation of RPS4 TIR altered the ratio of the binding partners in solution at an early stage of crystallization and resulted in RRS1 TIR -only crystal growth. RPS4 TIR was also prone to precipitation particularly after freeze/thawing. In an effort to promote/enforce the appropriate 1:1 stoichiometry, we covalently linked the RRS1 and RPS4 TIR domains with 5 (L5) and 11 (L11) residue linkers ( Fig. 2A) . Final yields of 2.5 and 5 mg/L were (Table I ). In SEC of the RRS1 TIR -L5-RPS4 TIR protein (Fig. 2C) , peaks in the void volume and at 130 and 155 ml were observed. SDS-PAGE (results not shown) revealed that both the second and third peaks contained RRS1 TIR -L5-RPS4 TIR , while the first peak consisted of contaminating proteins. The third peak had a similar elution volume to peak 1 in the SEC profile of the unlinked complex (Fig. 2B) , and SEC-MALS analysis revealed that peaks 2 and 3 corresponded to dimeric and monomeric forms of RRS1 TIR -L5-RPS4 TIR , respectively (Williams et al., 2014) . We speculate that the dimer peak ( peak 2) contained domain-swapped complexes, in which the RRS1 and RPS4 TIR domains from the two different molecules interact with each other. Protein concentrated from peak 3 was used for crystallization studies. Out of ∼800 conditions trialed, single hexagonally shaped crystals were obtained in a malonate screen and diffraction quality crystals were grown in 1.8 M sodium malonate, pH 6.0 (Fig. 2D) . The unlinked complex did not crystalize in the same condition, demonstrating that the linker was required for crystallization (Fig. 2D) . The crystals facilitated structure determination of the RRS1 TIR -RPS4 TIR complex at ∼2.7 Å resolution ( Fig. 2E ) (as reported in Williams et al. (2014) ). In light of this success, we used the same approach to investigate the TIR domain interaction between the related Arabidopsis TIR domain-containing NLR pair RPS4B and RRS1B (Saucet et al., 2015) . The domain organization of RPS4B and RRS1B is the same as RPS4 and RRS1, respectively. Both the RPS4B and RRS1B TIR domains had low expression levels in E.coli, and were prone to aggregation during the purification steps. We were therefore unable to confirm biophysically the interaction between RPS4B and RRS1B TIR domains using proteins expressed individually. However, the RRS1B TIR -L5-RPS4B TIR protein could be expressed and purified to homogeneity in E.coli ( Fig. 3A and B ) with a yield of 1 mg/l. The RRS1B TIR -L5-RPS4B TIR protein had a similar three-peak SEC profile to the RRS1 TIR -L5-RPS4 TIR protein; however, in this case the second peak (130 ml), which most likely corresponded to a dimeric form of RRS1B TIR -L5-RPS4B TIR , was the most predominant species. The protein comprising peak 2 was therefore used for crystallization studies. Initial hits from sparse matrix crystallization screens were observed in Index-A6 (100 mM Tris, pH 8.5, 2.0 M ammonium sulfate). To help control nucleation and increase crystal size, 10% glycerol was included in the crystallization solution (Fig. 3C) . The crystals diffracted X-rays to ∼8 Å resolution and crystallization optimization is under continued investigation.
Expression and purification of human TIR domain fusion proteins
In animals, TIR domains from TLRs and the cytosolic adaptor proteins MAL, MyD88, TRAM and TRIF are responsible for mediating receptor-receptor, receptor-adaptor and adaptor-adaptor interactions, all of which are crucial for TLR signal transduction. However, in solution, all animal TIR domains that have been biochemically characterized to date appear to behave as monomers, and complexes of receptor and adaptor TIR domains from purified components have not been reported in the literature (Ve et al., 2015) . At present, little is therefore known about the structural basis of the interactions between TIR domains in TLR pathways. In order to increase the local concentrations of the proteins and increase the probability of complex formation for structural studies, we designed, (Williams et al., 2014) . A color version of this figure is available as supplementary data at PEDS Online. expressed and purified multiple TIR domain fusion proteins (Table I) . Lipopolysaccharide-induced activation of the TLR4 leads to recruitment of the MAL and TRAM adaptors. MAL and TRAM are bridging adaptors that recruit the signaling adaptors MyD88 and TRIF, respectively, to the receptor, which leads to activation of distinct signaling pathways. We therefore designed TLR4-MAL, TLR4-TRAM, MAL-MyD88 and TRAM-TRIF TIR domain fusion proteins using both the L5 and L11 linkers. Upon activation, TLR2 has been shown to interact with MAL and MyD88 and we therefore designed both TLR2-MAL and TLR2-MyD88 fusion proteins. For these constructs, we only used the L5 linker. In total, we designed 10 fusion proteins and 6 of them (containing the MAL-MyD88, TRAM-TRIF, TLR2-MAL and TLR2-MyD88 fusion proteins) produced soluble protein.
Apart from the TLR2-MyD88 fusion protein, all of them could be purified to homogeneity using a combination of nickel affinity chromatography and SEC (Figs 4-6 and Table I ). SDS-PAGE analysis of the SEC elution peaks revealed that the MAL-MyD88, TRAM-TRIF and TLR2-MAL fusion proteins eluted in single monodisperse peaks and the volume of the peaks was consistent with the expected elution volume for a monomeric protein. Crystallization conditions for these mammalian TIR domain fusion proteins are currently being explored.
Discussion
In the present study, we utilized a linker strategy for the expression and purification of various TIR domain combinations that have been shown or have been predicted to interact. We demonstrate that this approach facilitates the soluble expression of TIR domain combinations in 9 of the 13 combinations that were investigated. In two instances, this protocol enabled the production of TIR domains that could not be produced when expressed independently. In addition, crystallization of two plant TIR domain combinations was achieved and this facilitated the structure determination of the RRS1-RPS4 TIR domain heterodimer (Williams et al., 2014) . The molecular detail provided by X-ray crystallography makes it the preferred technique when investigating protein-protein interactions. However, crystallography poses a problem of identifying the correct complex in the three-dimensional array of molecules packed in the crystals (Kobe et al., 2008) . Furthermore, crystallization of complexes is often more challenging than for individual proteins or domains. This is presumably due to the heterogeneity introduced due to the complex dissociation, and protein instability of one or more of the protein partners. In a survey of protein-protein complexes deposited in the Protein Data Bank, Radaev et al. reported that the crystallization parameters for complexes are more restricted than for single proteins (Radaev et al., 2006) . Despite access to commercially available sparse matrix screens specifically designed to optimize complex crystal formation success, in our hands these innovative products did not yield any crystals of complexes of TIR domains. The covalent attachment of protein domains presents a number of advantages for both expression and crystallization. During expression, a single polypeptide chain is translated; the stoichiometry of the interacting molecules therefore remains fixed. In addition, the fusion of one partner can improve the solubility of the other partner. For instance, the TIR domain of the TLR adaptor protein TRIF was insoluble in E.coli when expressed independently; however, it could be produced in a soluble form as a TRAM-TRIF TIR domain fusion. Similarly, the TIR domains of RPS4B and RRS1B were both prone to aggregation and precipitation when expressed individually in E.coli; however, when expressed as the linked construct RRS1B TIR -L5-RPS4B TIR , soluble protein was obtained. Linkers further assist in crystallization because the covalently attached proteins are spatially restrained, increasing the local concentration of the interacting partners. In the case of the RPS4 TIR -RRS1
TIR complex, maintaining stoichiometry appeared to be a critical issue to the formation of complex crystals. We observed that the RPS4 TIR domain was less stable than the RRS1 TIR domain and during initial crystallization trials of the complex, we frequently observed crystals of the RRS1 TIR domain alone. TIR domains have a globular flavodoxin-like fold and a topology that results in the close proximity of N and C termini. These features mean that we can easily predict the length requirements of a linker to allow the predicted interface to interact. We speculate that this technique would be appropriate and useful in expression and structural studies of other homotypic protein interaction domains, such as the members of the death domain superfamily (Park et al., 2007) . In summary, the results presented here describe a strategy for the production and purification of TIR domain complexes. This approach has been used successfully to improve protein production and facilitate structural studies of TIR domains from both the animal and plant innate immune receptors. The success we observed in these cases may make it a potential strategy for investigating alternative TIR-TIR domain interactions and other homotypic protein-protein interaction domains.
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